Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,584 GBX | -0.41% | -2.79% | +9.19% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.19% | 80.88B | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline : U.S. could control COVID by spring 2022 if more people get shots -Fauci